Form 8-K - Current report:
SEC Accession No. 0001193125-17-015301
Filing Date
2017-01-23
Accepted
2017-01-23 16:01:32
Documents
2
Period of Report
2017-01-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d334284d8k.htm 8-K 15003
2 EX-17.1 d334284dex171.htm EX-17.1 4944
  Complete submission text file 0001193125-17-015301.txt   21389
Mailing Address 2601 FOURTH AVENUE SUITE 500 SEATTLE WA 98121
Business Address 2601 FOURTH AVENUE SUITE 500 SEATTLE WA 98121 (206) 801-2100
Cascadian Therapeutics, Inc. (Filer) CIK: 0001412067 (see all company filings)

IRS No.: 260868560 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33882 | Film No.: 17541066
SIC: 8731 Services-Commercial Physical & Biological Research